Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemolysis Intravascular”

12 trials

Showing 12 of 12 results

Testing effectiveness (Phase 2)Study completedNCT03593200
What this trial is testing

A Phase IIa Study to Assess the Safety, Efficacy, and Pharmacokinetics of Subcutaneously Administered Pegcetacoplan (APL-2) in Subjects With PNH

Who this might be right for
PNH
Apellis Pharmaceuticals, Inc. 4
Large-scale testing (Phase 3)Looking for participantsNCT07154745
What this trial is testing

Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Regeneron Pharmaceuticals 35
Not applicableAvailableNCT05982938
What this trial is testing

Danicopan Early Access Program

Who this might be right for
Paroxysmal Nocturnal HemoglobinuriaPNHExtravascular Hemolysis
Alexion Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Study completedNCT00220727
What this trial is testing

Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Grifols Therapeutics LLC 8
Testing effectiveness (Phase 2)WithdrawnNCT03748082
What this trial is testing

Effects of Nitric Oxide on the Endothelium During Hemolysis.

Who this might be right for
Endothelial DysfunctionHemolysis IntravascularCardiovascular Diseases+1 more
Massachusetts General Hospital
Early research (Phase 1)Study completedNCT02264639
What this trial is testing

A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Apellis Pharmaceuticals, Inc. 9
Not applicableStudy completedNCT01641289
What this trial is testing

Paracetamol Effect on Oxidative Stress and Renal Function in Severe Malaria

Who this might be right for
Malaria
University of Oxford 62
Early research (Phase 1)Study completedNCT00095472
What this trial is testing

Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease

Who this might be right for
Sickle Cell Anemia
National Heart, Lung, and Blood Institute (NHLBI) 18
Post-approval studies (Phase 4)WithdrawnNCT04391231
What this trial is testing

HEMolysis in a Percutaneous Axial Flow LVAD, Effects of Pentoxifylline in a Randomized Controlled Trial

Who this might be right for
Hemolysis IntravascularAcute Decompensated Heart Failure
Cedars-Sinai Medical Center
Early research (Phase 1)Study completedNCT02588833
What this trial is testing

Pilot Study to Assess Safety, Preliminary Efficacy and Pharmacokinetics of S.C. Pegcetacoplan (APL-2) in PNH Subjects.

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Apellis Pharmaceuticals, Inc. 23
Not applicableUnknownNCT00502398
What this trial is testing

Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?

Who this might be right for
Pulmonary Artery Hypertension
Rabin Medical Center
Not applicableUnknownNCT06096428
What this trial is testing

Hemolysis During Pulsed-field and Radiofrequency Ablation

Who this might be right for
Atrial FibrillationHemolysisPulsed-field Ablation
Charles University, Czech Republic 60

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation